lan.png
EN
search.png
APl Development

Custom API development &Custom API manufacturing & Supply of Non-GMP API & Services and supply of clinical API

bantxtico.png
Organic Synthesis & Drug Modification

Innovative Drug Delivery, Excellence in Preclinical Development, Precise Process Scaling and GMP Supply Assurance

bantxtico.png
Drug Delivery

15 Years of Focused Expertise, Breakthrough Nanocarrier Technology for More Precise and Efficient Drug Delivery


bantxtico.png
Start
Drug Delivery System
We specialize in the innovation of drug delivery technologies, particularly in the design and development of microsphere and nanoparticle-based drug delivery systems. Our research team has over 15 years of industry experience, covering multiple key technological areas, including liposomes, hydrogels, microspheres, albumin nanoparticles, polymer micelles, and more. We offer comprehensive services from feasibility studies to process development and scale-up, ensuring smooth progress from proof of concept to commercial production. With flexible process development and scalable manufacturing capabilities, we are committed to providing efficient and reliable drug delivery solutions to our clients.
更换8.jpg
Liposomes
We specialize in the formulation and drug delivery technologies for a range of injectables, including traditional liposomes, stealth (PEGylated) liposomes for drug delivery, sustained-release liposomes, and solubility-enhancing systems such as microemulsions a...
更换9.jpg
Hydrogels
We focus on the design and development of a variety of hydrogels, including temperature-sensitive hydrogels, pH-sensitive hydrogels, and injectable hydrogels to meet diverse therapeutic needs. We offer full support, including formulation feasibility studies, p...
更换10.jpg
Microspheres
Our microsphere technology covers the development and characterization of biodegradable polymer microspheres, long-acting sustained-release microspheres, and targeted delivery microspheres. With extensive experience in process development, scale-up, and non-cl...
更换11.jpg
Albumin Nanoparticles
We focus on developing albumin-based nanoparticle drug delivery systems, particularly for targeted delivery of anticancer drugs and other potent therapeutics. Our services include full-process support from albumin nanoparticle formulation development, process ...
更换12.jpg
Polymeric Micelles
Our polymeric micelle technology encompasses the development of self-assembling micelles, targeted micelles, and responsive micelles. With deep expertise in polymer science and nanotechnology, we offer one-stop services from formulation optimization, process s...
更换13.jpg
Gold Nanoparticles
We provide gold nanoparticle development and application services, widely used in biomedical imaging, drug delivery, diagnostics, and therapy. We focus on the synthesis, surface modification, size control, and functionalization of gold nanoparticles, offering ...
更换5.jpg
Magnetic Nanoparticles
We offer custom development services for magnetic nanoparticles, suitable for targeted drug delivery, diagnostic imaging, and therapeutic applications. Our magnetic nanoparticle technology includes the synthesis and functionalization of superparamagnetic iron ...
更换15.jpg
Mesoporous Silica
We specialize in the development and application of mesoporous silica nanoparticles, particularly in the fields of drug delivery and bioimaging. Mesoporous silica nanoparticles possess unique pore structures and excellent loading capacities, enabling controlle...
更换16.jpg
Cell Membranes
We offer drug delivery system development services based on cell membrane encapsulation technology, aiming to utilize the biocompatibility and targeting properties of cell membranes for efficient drug delivery. Our cell membrane-coated nanoparticle technology ...
{$ImageUrl,alt}
API Development
We have a professional organic synthesis laboratory that can modify or adapt drugs, design and synthesize small molecule prodrugs. Our technical expertise lies in the design, synthesis, and kilogram-level supply of high molecular weight PEGylated products. We also focus on the chemical synthesis of ADC (antibody-drug conjugates), including linkers and the synthesis and combination of toxins. In the field of radiopharmaceuticals, we develop and synthesize cyclic molecules such as DOTA, NOTA, and linkers.
hapiico1.png hapiico1c.png
Drug Molecules & Intermediates & Prodrugs
We have state-of-the-art GMP facilities that offer multi-step, end-to-end continuous processing. Our extensive drug substance manufacturing capabilities are further enhanced, allowing us to advance your project from early development and optimization through to scale-up and commercial production. We provide manufacturing support at laboratory, kilogram, and pilot scales for all stages from preclinical research to clinical trials, supplying quantities ranging from milligrams to kilograms, while continuously improving chemical processes. We are also well-equipped to support your commercial manufacturing needs, including product launch and market supply, with capacities ranging from kilograms to over 100 metric tons.
01
hapiico2.png hapiico2c.png
PEGylation&Polymers&Copolymers
We offer customized PEGylation solutions,including the selection of different PEG molecular sizes, site-specific modifications, and the optimization of various PEGylation strategies. Our services include the development of targeted drug delivery systems for specific diseases such as cancer ans inflammation, leveraging polymer and copolymer design to enhance therapeutic efficacy. We also provide technology transfer services from laboratory research to large-scale production, assisting clients in achieving commercialization. 
02
hapiico3.png hapiico3c.png
ADC
We provide compound screening and synthesis, process development for novel monomers, linkers, and ligands, as well as the development and production of novel, highly specific ADC linkers at any scale. 
03
hapiico4.png hapiico4c.png
RDC
Our projects focus on the design of highly efficient chelators and their conjugation with linkers, providing clients with innovative and effective RDC solution. 
04
hapiico5.png hapiico5c.png
Dedicated platform
Dedicated platform
05
ABOUT
Our company is committed to promoting more drug research and market entry. we will use innovative thinking in organic synthesis & drug modification technology and nanotargeting & drug delivery technologies for preclinical development. we also specialize in scaling up the processes from preclinical research and providing GMP supply of raw materials and excipients, as well as GMP supply of nanotargeted formulations. Notably, our nanofreeze-drying technology, repeated freeze-thaw technology for nanomedicine, and high-concentration nanostabilization technology are part of our advanced processes, supporting large-scale production of nanoproducts.
更换19.jpg
  • hico1.png
    2012year
    Be established in
  • hico2.png
    82+
    Published papers
  • hico3.png
    1200+
    Served customers
  • hico4.png
    700+
    Have employees
NEWS
量子点2.jpg
Advancements in Liposomal Injectables: A New Era of Precision Drug Delivery
2025-02-05
更换23.jpg
Litchlab: Pioneering Smart Drug Release Mechanisms for Precision Treatment
2025-01-24
更换36.jpg
Litchlab: Pioneering Liposomal Technology for Precision Drug Delivery
2025-01-23